TORONTO, ON and NEW YORK, NY--(Marketwired - September 19, 2016) - iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN), which delivers a comprehensive solution for financing and managing licensed cannabis cultivators, processors and dispensaries throughout the United States, today announced the appointment of Paul Rosen and Richard Boxer, MD to the Company's Board of Directors in August 2016. iAnthus' board is now comprised of Hadley Ford, Julius Kalcevich, Randy Maslow, Richard Boxer, and Paul Rosen.
Dr. Boxer is a nationally respected U.S. health policy advisor, patient advocate, and medical quality assurance expert. Mr. Rosen has extensive experience in the legal medical cannabis industry in Canada as both an operator and financier.
"The iAnthus Board has been greatly enhanced by Paul Rosen's and Richard Boxer's collective expertise," said Randy Maslow, co-founder and President of iAnthus Capital Holdings. "Dr. Boxer has exceptional experience in public health policy with a distinguished track record of excellence in his field and Paul Rosen brings tremendous experience in the field of medical marijuana as well as financial acumen, broad operational experience and demonstrated leadership skills. We look forward to their contributions and working closely with both of these leaders as we continue to build iAnthus."
Dr. Boxer is currently a visiting scholar and clinical professor in urology at the UCLA Medical Center. He was a finalist for Surgeon General of the United States in 1997 in the Bill Clinton Administration and again in 2001 in the George W. Bush Administration. Dr. Boxer served as a Senior Advisor in the White House in 1993 and has also served on the Board of Directors of the National Cancer Institute (NCAB), the Board of the National Institute of Diabetes, Kidney and Digestive Diseases (NIDDK) from 1995-2002, and as a US Delegate to the World Health Organization in 1997. From 2006 to 2013 Dr. Boxer was the Chief Medical Officer at Teladoc, which created the national standard of care for telemedicine under Dr. Boxer's direction.
Mr. Rosen is a founder and acting President of RG2 Partners, a Toronto based advisory and incubator active within the global cannabis industry. Mr. Rosen most recently served as President and CEO of PharmaCan Capital Corporation, a publicly traded merchant bank focused on investing in Canada's medical marijuana industry, a company which he co-founded. While CEO at PharmaCan, Mr. Rosen concurrently served as President of In The Zone Produce Ltd., a Canadian medical marijuana producer licensed by Health Canada. Mr. Rosen currently acts as Chairman of Lift Cannabis and sits on the Boards of MVC Technologies and Tokyo Smoke.
iAnthus began trading on the Canadian Securities Exchange in September 2016 and previously announced the closing of a US$6.7 million private placement in May, 2016. Funds from the private placement will be used to invest in its existing partners in Massachusetts, New Mexico and Vermont and for general working capital purposes.
Additional information about iAnthus Capital Holdings may be accessed on the Company's website at www.ianthuscapital.com and in its Listing Statement (the "Listing Statement"), which describes the businesses of the Company, and is available on the SEDAR website at www.sedar.com.
About iAnthus Capital Holdings
iAnthus Capital Holdings, Inc., through its 100% owned subsidiary, iAnthus Capital Management, LLC, delivers a comprehensive solution for financing and managing licensed cannabis cultivators, processors and dispensaries throughout the United States. Founded by entrepreneurs with decades of experience in investment banking, corporate finance, law and healthcare services, iAnthus provides a unique combination of capital and hands-on operating and management expertise. The Company harnesses these skills to support a diversified portfolio of cannabis industry investments for our shareholders, including direct equity investments in for-profit license holders and lending facilities coupled with management services to not-for-profit license holders. For more information, visit www.ianthuscapital.com.
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.